Association of tenofovir and entecavir use with prognosis after surgical resection for hepatitis B virus-related hepatocellular carcinoma

被引：4
作者：
Yun, Byungyoon [1 ]
Ahn, Sang Hoon [2 ,3 ,4 ]
Oh, Juyeon [5 ]
Yoon, Jin-Ha [1 ,6 ]
Kim, Beom Kyung [2 ,3 ,4 ]
机构：
[1] Yonsei Univ, Dept Prevent Med, Coll Med, Seoul, South Korea
[2] Yonsei Univ, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
[3] Yonsei Univ, Inst Gastroenterol, Coll Med, Seoul, South Korea
[4] Yonsei Univ Hlth Syst, Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea
[5] Yonsei Univ, Grad Sch, Dept Publ Hlth, Coll Med, Seoul, South Korea
[6] Yonsei Univ, Dept Occupat Hlth, Dept Prevent Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
来源：
EUROPEAN JOURNAL OF INTERNAL MEDICINE | 2022年 / 103卷
关键词：
Hepatitis B virus; Hepatocellular carcinoma; Curative treatment; Surgery; Recurrence; Death; Comparison; Antiviral therapy; Entecavir; Tenofovir; CURATIVE TREATMENT;
D O I：
10.1016/j.ejim.2022.07.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：122 / 125
页数：4
相关论文
共 10 条
  • [1] Interferon lambda-3 is not associated with clinical outcome in patients with HCV-induced compensated cirrhosis: A long-term cohort study
    Bruno, Savino
    Thompson, Alex J.
    Critelli, Rosina
    Crosignani, Andrea
    Rossi, Sonia
    De Lisi, Stefania
    Cariani, Elisabetta
    Zermiani, Paola
    Vaira, Valentina
    Boccaccio, Vincenzo
    Maisonneuve, Patrick
    Villa, Erica
    [J]. ANTIVIRAL RESEARCH, 2015, 113 : 27 - 32
  • [2] Tenofovir Versus Entecavir on Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma After Surgical Resection
    Choi, Jonggi
    Jo, Chanyoung
    Lim, Young-Suk
    [J]. HEPATOLOGY, 2021, 73 (02) : 661 - 673
  • [3] Endogenous IFNλ in Viral Hepatitis Patients
    de Groen, Rik A.
    Mcphee, Fiona
    Friborg, Jacques
    Janssen, Harry L. A.
    Boonstra, Andre
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2014, 34 (07) : 552 - 556
  • [4] The efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis B virus-related hepatocellular carcinoma
    Lee, Ji Hyun
    Kim, Beom Kyung
    Park, Soo Young
    Tak, Won Young
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Sinn, Dong Hyun
    Kim, Seung Up
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 89 : 48 - 55
  • [5] Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma
    Lee, Sung Won
    Choi, Jonggi
    Kim, Seung Up
    Lim, Young-Suk
    [J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2021, 27 (03) : 402 - 412
  • [6] Tenofovir Is Superior to Entecavir on Tertiary Prevention for BCLC Stage 0/A Hepatocellular Carcinoma after Curative Resection
    Tsai, Ming-Chao
    Wang, Chih-Chi
    Lee, Wei-Chen
    Lin, Chih-Che
    Chang, Kuo-Chin
    Chen, Chien-Hung
    Hung, Chao-Hung
    Lin, Ming-Tsung
    Hsiao, Chang-Chun
    Chen, Chao-Long
    Chien, Rong-Nan
    Hu, Tsung-Hui
    [J]. LIVER CANCER, 2021, : 22 - 37
  • [7] Antiviral therapy after curative treatment of hepatocellular carcinoma in patients with chronic hepatitis B infection: Is tenofovir or entecavir preferred?
    van Erpecum, Karel J.
    Sonneveld, Milan J.
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 89 : 27 - 29
  • [8] Tenofovir vs. entecavir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative resection
    Wang, Xiao-Hui
    Hu, Zi-Li
    Fu, Yi-Zhen
    Hou, Jing-Yu
    Li, Wen-Xuan
    Zhang, Yao-Jun
    Xu, Li
    Zhou, Qun-Fang
    Chen, Min-Shan
    Zhou, Zhong-Guo
    [J]. JOURNAL OF GASTROENTEROLOGY, 2022, 57 (03) : 185 - 198
  • [9] Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop
    Yim, Hyung Joon
    Kim, Ji Hoon
    Park, Jun Yong
    Yoon, Eileen L.
    Park, Hana
    Kwon, Jung Hyun
    Sinn, Dong Hyun
    Lee, Sae Hwan
    Lee, Jeong-Hoon
    Lee, Hyun Woong
    [J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2020, 26 (04) : 411 - 429
  • [10] KASL clinical practice guidelines for management of chronic hepatitis B
    Yim, Hyung Joon
    Kim, Ji Hoon
    Park, Jun Yong
    Yoon, Eileen L.
    Park, Hana
    Kwon, Jung Hyun
    Sinn, Dong Hyun
    Lee, Sae Hwan
    Lee, Jeong-Moon
    Lee, Hyun Woong
    [J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2019, 25 (02) : 93 - 159
1